We have shown that propranolol reduces oxygen binding by hemoglobin in intact red cells by increasing the selective permeability of the red cell membrane resulting in an exodus of potassium, chloride, and water. The latter effects result in a new distribution of hydrogen ion between cell and plasma, and thereby a reduction in red cell pH. The reduction in pH can fully explain the change in hemoglobin's affinity for oxygen based on the Bohr effect. Either D-or DL-propranolol can produce the change in red cell pH and oxygen binding by hemoglobin. The drug action on permeability is not prevented by epinephrine, although it is by chlorbutanol. Hence, the membrane action of propranolol does not appear to be related to its activity as a beta-adrenergic receptor blocking agent.
THE DISCOVERY of the effect of red cell 2,3-DPG on hemoglobin-oxygen affinity1 led to the recognition that modulation of affinity by pharmacologic means might be useful. In an attempt to identify agents which might improve oxygen release by hemoglobin, scientists at Smith, Kline and French laboratories described the ability of propranolol to reduce oxygen affinity of hemoglobin in human red cells in vitro.2 The precise mechanism for the effect was not defined. The concentrations required to produce effects on affinity in vitro were several orders of magnitude greater than those which can be achieved in vivo based on pharmacokinetic studies of propranolol in man. 3 Nevertheless, propranolol was reported subsequently to be capable of decreasing the oxygen-binding property of hemoglobin when administered in small doses to human subjects. 4 We have examined further the effects of propranolol on human red cells in vitro and in vivo in order to 1) explore the mechanism by which affinity is altered in vitro, 2) re-examine the relationship of the propranolol effect to its f3-adrenergic blocking activity, and 3) re-examine the effect on affinity when the drug is administered to human subjects.
Methods

Preparation of Blood
Blood was collected from the antecubital vein of healthy subjects and anticoagulated with sodium heparin. One-fifth volume of a solution of propranolol, epinephrine, or chlorbutanol dissolved in 0.15 M NaCl solution was added to blood to achieve the final concentration required by individual experiments. Blood in 10 ml tubes was centrifuged at 5,650 X g for 15 min in inverted position (stopper down). The packed red cells were aspirated into a syringe from which samples were expressed into both microhematocrit tubes and volumetric micropipettes. This technique allowed measurements to be made without washing treated cells. The red cells were packed to a volume of 97 to 98.5%. 15 to 60 torr while pCO2 was maintained at 40 ± 0.2 torr. Each determination was made in duplicate. The P02 at which hemoglobin was 50% saturated at 370C, pH 7.4, pCO2 = 40 torr (P,0 std) was derived from the curve drawn through these experimental points, using a least squares analysis.
Red Cell pH
Blood was centrifuged at 40C with tubes inverted (rubber stopper down) at 5,650 X g for 15 min. The packed red cell layer was aspirated into a 3 ml plastic syringe containing a stainless steel washer as a mixer. A small sample was expressed into microcapillary tubes and PCV measured. The latter was always >95%. Fifty microliters of 0.7 M sodium fluoride per ml of packed red cells were added anaerobically to the syringe which was mixed vigorously, later frozen at -70°C overnight and thawed at room temperature. The pH of the lysate was measured in an Instrumentation Laboratory Model 113 pH meter at 37°C.
Hemoglobin Solutions
Solutions of human hemoglobin prepared from red cell hemolysates, free of stroma and of organic phosphates, were made by the method of Udkow et al.7
Membrane and Cytosol 2,3-DPG Blood with and without 0.5 mM propranolol, with the plasma and buffy coat removed, was centrifuged at 1,000 X g. Two milliliters of packed cells were added to 10 ml of distilled water for 20 min at 2°C. Three milliliters of the hemolysate was removed, number of ghosts counted, and hemoglobin concentration and 2,3-DPG content measured. The remaining 9 ml were centrifuged at 35,000 X g for 30 min. The supernatant was removed and number of ghosts, hemoglobin, and 2,3DPG measured in the supernatant and in the sediment. Seven-tenths of a milliliter of a solution containing 1.42 M KCI + 0.28 M NaCl was added to 7.0 ml of the supernatant from the previous centrifugation and the latter was recentrifuged at 35,000 X g for 30 min. The supernatant and sediment of this centrifugation was removed, and ghosts counted, hemoglobin and 2,3-DPG concentration measured in both fractions.
Effect of Propranolol in Vivo
Six healthy volunteers were given propranolol by mouth over a 2 to 4 hour interval (total dose 20 to 40 mg). Red cell pH, 2,3-DPG, ATP, and oxygen binding by hemoglobin were determined before 4 hours and 24 hours after the first dose of propranolol. In addition, two patients on large doses of propranolol (180 and 360 mg) were studied.
Results
Effect of Propranolol on Red Cell Hemoglobin, Ion and Water Content and pH
The addition of DL-or D-propranolol to human blood for 20 min at 37°C produced a marked decrease in the binding of oxygen to hemoglobin (table 1) . This was not accompanied by a significant change in the content of red cell 2,3-DPG or ATP expressed per gram of hemoglobin. However, the major red cell impenetrant anions 2,3-DPG, ATP and hemoglobin did increase significantly in concentration when considered per volume of cells or per volume of cellular water (table 1) . Propranolol produced a 30% mean decrease in red cell volume from 89 ± 1.0 to 62 ± 0.7 Am3. The reduction in red cell volume was the result of the exodus of potassium, chlodide, and water from the cell (table 2) . The concentration of red cell sodium and chloride was slightly greater than that observed in washed red cells due to the percent of plasma trapped during the microhematocrit measurement and due to the increase in plasma chloride produced by adding drugs in 1/5 volume 0.15 M NaCI. The absolute loss of potassium exceeded the increment in sodium, causing marked dehydration of the red cell. This change reached an apparent steady-state maximal effect at 20 to 25 min at 37°C. In association with the marked change in ion distribution and concentration after propranolol was added to blood, red cell pH was reduced and plasma pH increased significantly, indicating a shift of hydroxyl ions from cells to plasma (table 3) . propranolol were not blocked by DL-epinephrine when studied at one to ten fold the molarity of propranolol. Epinephrine at a concentration as high as 5 mM had no effect on shape, ion content, or oxygen hemoglobin affinity of red cells.
The effects of propranolol on both the permeability of the red cell membrane to potassium chloride and on cell volume could be blocked by adding 3 mM chlorbutanol and 0.5 mM propranolol to blood, yet the stomatocytic shape change of the red cell persisted. Chlorbutanol itself had no effect on red cell shape or volume.
Effect of Propranolol on Hemoglobin Solutions
Propranolol added to hemoglobin solutions stripped of organic phosphates had no effect on oxygen binding to hemoglobin, whereas 2,3-DPG or pyridoxal-5-phosphate added to the identical hemoglobin solutions produced the expected decrease in oxygen binding for the ligand to hemoglobin molar ratios Six human subjects were given up to 40 mg of propranolol by mouth. Red cell pH, 2,3-DPG, and P,0 were unchanged 4 hours and 24 hours after administration of the drug (table 5) . In each case a pharmacologic effect of the drug was evident in that electrocardiograms documented the occurrence of a significant reduction in heart rate after drug ingestion. In some cases bradycardia prevented the administration of the full 40 mg dose. In no case did a change in oxygen binding to hemoglobin occur. Moreover, two subjects on large doses of propranolol (180 and 360 mg/day) had red cell volume, shape, pH, and an oxygen-hemoglobin dissociation curve which was xvithin one standard deviation of the normal mean and at the expected position for their red cell 2,3-D)PG content.
Discussion
Methods to alter red cell 2,3-DCP have received considerable attention because of the possible importance of such techniques in the management of ischemic or hypoxic states. During the screening of drugs for their possible usefulness in this regard, scientists at Smith, Kline, and French laboratories discovered the efficacy of propranolol on altering oxygen-hemoglobin affinity.2 The effect on affinity was predictable based on the studies of Ekman et al."' and The concentration of propranolol required to achieve effects on oxygen binding to hemoglobin in vitro is enormous compared to the expected concentrations from amounts of the drug tolerated by human subjects. Based on the studies of Shand and Rango,4 the concentration of propranolol in blood after a 40 mg dose is three orders of magnitude lower than the concentration required to produce effects on oxygenhemoglobin affinity in human blood in vitro. The absence of effects on affinity in human subjects given the drug was not unexpected, therefore. These results differ from a previous report suggesting that the mechanism of action of propranolol in humans may relate to an enhancement of oxygen release by hemoglobin.3
